Motif Bio Share Discussion Threads

[hazl] 26/6/2015 09:43

don't forget that funding is always neccessary for these firms to succeed,this is an exciting firm ,in my opinion.

from recent rns

' Graham Lumsden, CEO, commented:

"Following so quickly on from our AIM-listing in early April 2015, and the FDA's approval of our proposed Phase III clinical development programme for iclaprim on April 15, I am very pleased to see this level of support and confidence from institutions. At our IPO, we indicated that we would, with sufficient funding, be in a position to commercialise iclaprim within 36 months of our listing, and this fund-raising is key to realising this exciting goal. We are confident that we remain on target."

IMO

[baldrick1] 26/6/2015 09:24

Next news will be July 11th when placing price of 50p hits the market.Funny how the those who already taken this placement are trying to boost price up.obvious sort of manipulation imho

[hazl] 26/6/2015 08:46

I don't imagine we will be short of news here...
IMO

[hazl] 25/6/2015 13:06

Look what can happen when a thing goes to the US.
AMSU.



IMO

Of course this is no guarantee.

[hazl] 25/6/2015 10:13

talking of futures the Dow looks better for this afternoon....at this point anyway.8-)

IMO

[regandharry5] 24/6/2015 16:55

hazl.... True, the futures good ,the futures HOT.

[bad robot] 24/6/2015 15:03

Creeping up.

[bad robot] 24/6/2015 14:10

Phase 3 trials are very valuable. Biggies will have their eyes on MTFB. They will buy them off.

MTFB should dual list on NASDAQ then you will see trading at 500p-1000p

[hazl] 24/6/2015 13:57

very hot sector...would agree

[bad robot] 24/6/2015 12:20

a 75p close today will be wicked and it should propell our baby to nearer triple digits

[hazl] 24/6/2015 12:20

Its the future that matters and this is a very hot sector, the fact they can easily get support for the financing they need,in my opinion, is supporting this.

[bad robot] 24/6/2015 12:18

Broke out.

Next stop 90

[regandharry5] 24/6/2015 11:01

Must confess I didn't think we would see 70p so soon after dilution.

A lot of those went to II's so maybe that helps.

[germanicus] 24/6/2015 10:50

Break out!

GLA

[hazl] 24/6/2015 09:29

Reaching American attention?

[hazl] 24/6/2015 08:43

Its an important area

IMO

[mirabeau] 24/6/2015 08:35

Stonking response and nearly into new highs. Impressive performance considering this week's dilution

[timbo003] 24/6/2015 07:57

There is a brief summary of the Northland note (target 89p/share) here:

[hazl] 24/6/2015 07:47

Yes miraubeau I saw those Northland Capital targets last night on two different sites,I think 'sleek money was one . 8-)


Ah Dakota financial news as well

[mirabeau] 24/6/2015 06:32

'Floated on AIM at 20p in April, Motif Bio firmed a penny to 65.25p following an institutional placing of 44million shares at 50p a pop, raising £22million. Cash raised will be used towards the company’s phase III trials and roll out of its lead antibiotic, iClaprim, designed to be effective against serious and life-threatening infections caused by multi-resistant bacteria.

Vadim Alexandre, analyst at joint broker Northland Capital, said that his target price is 89p. He added: ‘The proceeds will allow the company to rapidly progress iClaprim into the clinic. It is set to fill a major market void.’

[shackleton1] 23/6/2015 22:36

Forget this rubbish about Institutions shorting shares once they know of a potential placing. Firstly, you have to declare a short position, and you can only sell a stock you don't own if you have secured a borrow facility. Not possible these days and highly unlikely so good luck.

[regandharry5] 23/6/2015 17:05

Interesting article , but I wonder why there is no mention of the recent partnership?